To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1457924
Sale price594,74 €
|
Nefazodone Related Compound B (25 mg) (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride) |
F0F124 | N/A | 594,74 € | |
|
USP-1458031
Sale price387,92 €
|
Neomycin Sulfate System Suitability Mixture (100 mg) |
F11060 | N/A | 387,92 € | |
|
USP-1458042
Sale price717,42 €
|
Neohesperidin (30 mg) ((S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) |
R134R0 | 13241-33-3 | 717,42 € | |
|
USP-1458064
Sale price335,34 €
|
Neodiosmin (30 mg) (5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-Dglucopyranoside) |
F097P0 | 38665-01-9 | 335,34 € | |
|
USP-1458086
Sale price394,93 €
|
Neohesperidin Dihydrochalcone (500 mg) (3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenyl 2-O-(alpha-L-rhamnopyranosyl)-Beta-D-glucopyranoside) |
F097F0 | 20702-77-6 | 394,93 € | |
|
USP-1460010
Sale price876,33 €
|
Neostigmine Related Compound A (15 mg) (3-Hydroxy-N,N,N-trimethylbenzenaminium bromide) |
F212Y0 | 1620-19-5 | 876,33 € | |
|
USP-1460021
Sale price677,70 €
|
Neostigmine Related Compound B (15 mg) (3-(Dimethylamino)phenol) |
F21300 | 99-07-0 | 677,70 € | |
|
USP-1460032
Sale price876,33 €
|
Neostigmine Related Compound C (15 mg) (3-(Dimethylamino)phenyl dimethylcarbamate) |
F21310 | 16088-19-0 | 876,33 € | |
|
USP-1460215
Sale price1.059,78 €
|
Neotame Related Compound A (15 mg) (N-[N-(3,3-Dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine) |
R20460 | 190910-14-6 | 1.059,78 € | |
|
USP-1460328
Sale price951,11 €
|
Nepafenac Related Compound A (25 mg) (2-{2-Amino-3-[hydroxy(phenyl)methyl]phenyl}acetamide) |
F129V0 | 1246956-18-2 | 951,11 € | |
|
USP-1460339
Sale price941,76 €
|
Nepafenac Related Compound B (25 mg) (7-Benzoylindolin-2-one) |
F130V0 | 51135-38-7 | 941,76 € | |
|
USP-1460725
Sale price1.097,17 €
|
Nevirapine Related Compound A (15 mg) (5,11-dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one) |
R08110 | 133627-17-5 | 1.097,17 € | |
|
USP-1460736
Sale price1.055,10 €
|
Nevirapine Related Compound B (10 mg) (5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one) |
R18090 | 287980-84-1 | 1.055,10 € | |
|
USP-1460747
Sale price1.076,14 €
|
Nevirapine Related Compound C (15 mg) (5,11-Dihydro-6H-11-propyl-4-methyl-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one) |
F0M426 | N/A | 1.076,14 € |
